ClinicalTrials.gov
public full text
Public Domain
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
The investigators would like to find out if sitagliptin (dipeptidyl peptidase-4 or DPP4 inhibition), a drug to treat diabetes, affects blood vessel relaxation in healthy people receiving enalapril (angiotensin converting enzyme or ACE inhibition), a blood pressure medicine. Understanding how these drugs interact in healthy people will help us learn their potential effects in people who have diabetes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevention of Diabetes and Hypertension#1047295
- Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction#1057068
- Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema#1030499
- Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment#272285
- Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance#880957
Record · ID 854932
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive